SCHEMBL7410241

SCHEMBL7410241

CCCOC(=O)OC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
SOAT1 P35610 1/20 0.46
TSHR P16473 5/20 0.43
LMNA P02545 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HCAR2 Q8TDS4 1/20 0.40
NAAA Q02083 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
CHRM1 P11229 3/20 0.36
ESR1 P03372 1/20 0.36
SLC6A2 P23975 1/20 0.36
KDR P35968 1/20 0.36
CHRM5 P08912 2/20 0.34
CHRM3 P20309 2/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
HTR1A P08908 1/20 0.34
CHRNB2 P17787 1/20 0.34
TBXA2R P21731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497149 0.87 SOAT1 (0.60) ALDH1A1SOAT1TSHRLMNAHSD17B10
SCHEMBL4461109 0.86 ALDH1A1 (0.67) ALDH1A1SOAT1TSHRLMNAHCAR2
SCHEMBL27669941 0.82 NAAA (0.61) ALDH1A1TSHRLMNAHCAR2NAAA
SCHEMBL6354928 0.81 TDP1 (0.44) ALDH1A1SOAT1TSHRLMNAHSD17B10
SCHEMBL17057 0.81 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAHSD17B10
SCHEMBL27957695 0.80 NAAA (0.46) ALDH1A1SOAT1TSHRLMNAHCAR2
SCHEMBL8848622 0.80 SOAT1 (0.75) ALDH1A1SOAT1TSHRLMNAHSD17B10
SCHEMBL25630260 0.80 ALDH1A1 (0.58) ALDH1A1TSHRLMNAHSD17B10HCAR2
SCHEMBL2497152 0.80 SOAT1 (0.46) ALDH1A1SOAT1TSHRLMNAHCAR2
SCHEMBL2161093 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140271489-A1 POLYMERIC DEPOTS FOR LOCALIZATION OF AGENT TO BIOLOGICAL SITES TRUSTEES OF BOSTON UNIVERSITY (US) 2014-09-18 US disclosed
US-20140271489-A1 POLYMERIC DEPOTS FOR LOCALIZATION OF AGENT TO BIOLOGICAL SITES TRUSTEES OF BOSTON UNIVERSITY (US) 2014-09-18 US disclosed
US-20130195954-A1 FILMS AND PARTICLES THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2013-08-01 US disclosed
US-20130195954-A1 FILMS AND PARTICLES THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2013-08-01 US disclosed
US-8338492-B2 Films and particles THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2012-12-25 US disclosed
US-8338492-B2 Films and particles THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2012-12-25 US disclosed
US-8334324-B2 Films and particles THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2012-12-18 US disclosed
US-8334324-B2 Films and particles THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2012-12-18 US disclosed
US-20120107365-A1 FILMS AND PARTICLES THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2012-05-03 US disclosed
US-20120107365-A1 FILMS AND PARTICLES THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2012-05-03 US disclosed
US-20110152305-A1 FILMS AND PARTICLES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2011-06-23 US disclosed
US-20110152305-A1 FILMS AND PARTICLES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2011-06-23 US disclosed
US-7671095-B2 Films and particles THE TRUSTEES OF THE BOSTON UNIVERSITY (US) 2010-03-02 US disclosed
US-20080075718-A1 Films and Particles THE TRUSTEES OF THE BOSTON UNIVERSITY 2008-03-27 US disclosed
EP-1047690-A1 HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION Abbott Laboratories (US) 2000-11-02 EP disclosed
WO-1999032480-A1 HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION ABBOTT LABORATORIES (US) 1999-07-01 WO disclosed
WO-1991011448-A1 THERAPEUTIC AGENTS THE BOOTS COMPANY PLC (GB) 1991-08-08 WO disclosed
WO-1990001481-A1 THERAPEUTIC AGENTS THE BOOTS COMPANY PLC (GB) 1990-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152305-A1 FILMS AND PARTICLES APOB, PGF, ACTB ALDH1A1 2505/4885SOAT1 3553/4885TSHR 4398/4885
US-20130195954-A1 FILMS AND PARTICLES APOB, PGF, ACTB ALDH1A1 2505/4885SOAT1 3553/4885TSHR 4398/4885
US-20080075718-A1 Films and Particles APOB, PGF, ACTB ALDH1A1 2505/4885SOAT1 3553/4885TSHR 4398/4885
US-20140271489-A1 POLYMERIC DEPOTS FOR LOCALIZATION OF AGENT TO BIOLOGICAL SITES CD68, LPXN, CXCL12 ALDH1A1 3186/4885SOAT1 3182/4885TSHR 1913/4885
US-20120107365-A1 FILMS AND PARTICLES APOB, PGF, ACTB ALDH1A1 2505/4885SOAT1 3553/4885TSHR 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.